Aprotinin for Injection

Carboxypeptidase Injection is used to treat acute pancreatitis by inhibiting the breakdown of peptides, thus reducing the level of inflammatory mediators and protecting the pancreas from further damage.

This injection helps control digestive enzyme activity in patients with severe disorders like pancreatic insufficiency or enzyme overproduction, allowing the digestive system to function more effectively.

Carboxypeptidase can be used in the treatment of protein metabolism disorders, where excessive peptide cleavage is causing metabolic imbalances. It helps regulate the breakdown of protein chains into amino acids.

Used for conditions where enzymatic inhibition is required to slow down peptide degradation, thereby improving nutrient absorption, wound healing, and overall protein synthesis.

By reducing excessive enzymatic activity, Carboxypeptidase Injection supports wound healing and tissue regeneration after injury, helping maintain cellular integrity and promoting recovery in tissues affected by trauma or surgery.

This treatment is sometimes used in conditions where inflammatory responses are excessive, such as rheumatoid arthritis or sepsis, by inhibiting the breakdown of peptides involved in the inflammatory process.